ORAL, NON-CHEMOTHERAPY: First approved treatment of its kind
Image of a busy outdoor scene that is paused to draw focus on a grandfather kneeling to give an ice cream cone to his granddaughter.
For adults with metastatic pancreatic cancer (adenocarcinoma) who have received at least
1 prior treatment or who cannot receive a combination of cancer treatments
MORE TIME
for what matters
Actor portrayal.
RASONQUE is not for use in children.
In a clinical trial, people who were treated with RASONQUE had a median overall survival of 13.2 months vs 6.6 months for those treated with chemotherapy. Median overall survival is the length of time when half the people on treatment are still living.
spacing-35
mobile-spacing-40
spacing-30
mobile-spacing-45